Filgotinib in ulcerative colitis: early real-world experience in Southampton

被引:0
|
作者
Taylor, Deborah [1 ]
Young, David [1 ,2 ]
Rahmany, Sohail [1 ]
Bettey, Marion [1 ]
Oppong, Philip [1 ]
Harris, Richard [1 ]
Smith, Trevor [1 ]
Felwick, Richard [1 ]
Gwiggner, Markus [1 ]
Cummings, Fraser [1 ,2 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Univ Southampton, Southampton, Hants, England
关键词
D O I
10.1136/gutjnl-2023-BSG.186
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P114
引用
收藏
页码:A113 / A113
页数:1
相关论文
共 50 条
  • [31] Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
    Honap, Sailish
    Chee, Desmond
    Chapman, Thomas P.
    Patel, Mehul
    Kent, Alexandra J.
    Ray, Shuvra
    Sharma, Esha
    Kennedy, James
    Cripps, Sarah
    Walsh, Alissa
    Goodhand, James R.
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter M.
    Kennedy, Nicholas A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (10): : 1385 - 1393
  • [32] Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience
    Honap, Sailish
    Pavlidis, Polychronis
    Ray, Shuvra
    Sharma, Esha
    Anderson, Simon
    Sanderson, Jeremy D.
    Mawdsley, Joel
    Samaan, Mark A.
    Irving, Peter M.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : E147 - E149
  • [33] REAL-WORLD EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS - A META-ANALYSIS OF OBSERVATIONAL STUDIES
    Lucaciu, Laura
    Constantine-Cooke, Nathan
    Plevris, Nikolas
    Siakavellas, Spyros I.
    Jones, Gareth R.
    Lees, Charlie W.
    GASTROENTEROLOGY, 2021, 160 (06) : S709 - S709
  • [34] REAL-WORLD EXPERIENCE WITH CURCUMIN-QINGDAI IN MANAGING ADULTS WITH ACTIVE ULCERATIVE COLITIS
    Peraza, Jellyana
    Salomon, Nir
    George, James
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S73 - S74
  • [35] A SINGLE-CENTRE, REAL-WORLD EXPERIENCE OF TREATING ULCERATIVE COLITIS PATIENTS WITH VEDOLIZUMAB
    Lenti, M. V.
    Cococcia, S.
    Giuffrida, P.
    Aronico, N.
    Soriano, S.
    Corazza, G. R.
    Di Sabatino, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E202 - E203
  • [36] Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
    Mocci Md Frcp, G.
    Costa, F.
    Ceccarelli, L.
    Savarino, E.
    Mucherino, C.
    Marzo, M.
    Scaldaferri, F.
    Napolitano, D.
    Pugliese, D.
    Gravina, A. G.
    Pellegrino, R.
    Spagnuolo, R.
    Cuomo, A.
    Maconi, G.
    Bertani, L.
    Bodini, G.
    Orru, G.
    Piergallini, S.
    Scarcelli, A.
    Capone, P.
    Cortellini, F.
    Rodino, S.
    Vespere, G.
    Gaiani, F.
    Pagnini, C.
    Graziani, G.
    Allegretta, L.
    Ferronato, A.
    Ribaldone, D. G.
    Aragona, G.
    Forti, G.
    Di Fonzo, M.
    Iacopini, F.
    Pica, R.
    Onidi, M. F.
    Usai Satta, P.
    Elisei, W.
    Picchio, M.
    Papa, A.
    Tursi, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1946 - i1946
  • [37] Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study
    Buisson, A.
    Treton, X.
    Nachury, M.
    Uzzan, M.
    Bouguen, G.
    Hamadidi, A. Banana
    Amiot, A.
    Serrero, M.
    Fumery, M.
    Caillo, L.
    Hupe, M.
    Pereira, B.
    Altwegg, R.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1212 - i1212
  • [38] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [39] REAL-WORLD EXPERIENCE AND PERSPECTIVES ON THE TREATMENT OF ULCERATIVE COLITIS: RESULTS FROM A HEALTHCARE PROVIDER SURVEY
    Hunter, Theresa
    Sweeney, Carolyn
    Wolin, Daniel
    McSorley, David
    Wang, Jinyi
    Koushik, Amit Kumar
    Moses, Richard
    Dubinsky, Marla
    GASTROENTEROLOGY, 2024, 166 (03) : S117 - S118
  • [40] Australian multicenter real-world experience of upadacitinib induction therapy for moderate to severe ulcerative colitis
    Gilmore, R.
    Fernandes, R.
    Hartley, I.
    Arzivian, A.
    Leong, R.
    Andrew, B.
    Vasudevan, A.
    Greeve, T.
    Moore, G.
    Kim, S.
    Lightowler, D.
    Singh, A.
    Mahy, G.
    Mithanthaya, A.
    Venugopal, K.
    Han, S.
    Bryant, R.
    Corte, C.
    Ding, J. N.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 185 - 186